Issue 3/2024
Content (11 Articles)
Salivary Therapeutic Drug Monitoring of Antimicrobial Therapy: Feasible or Futile?
Lina Davies Forsman, Hannah Yejin Kim, Thi Anh Nguyen, Jan-Willem C. Alffenaar
Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy
Yi Ma, Zaiwei Song, Xinya Li, Dan Jiang, Rongsheng Zhao, Zhanmiao Yi
Safety and Pharmacokinetics of HRS-2261, a P2X3 Receptor Antagonist, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
Yuru Fan, Xuan Zhang, Qin Zhang, Liang Zheng, Renpeng Zhou, Cheng Sun, Xihan Wang, Ke Song, Zhusheng He, Honghui Wang, Qian Zhang, Wei Hu
Population Pharmacokinetic/Pharmacodynamic Models for P2Y12 Inhibitors: A Systematic Review and Clinical Appraisal Using Exposure Simulation
Jingcheng Chen, Yuchen Qu, Muhan Jiang, Haiyan Li, Cheng Cui, Dongyang Liu
Maternal Ezetimibe Concentrations Measured in Breast Milk and Its Use in Breastfeeding Infant Exposure Predictions
Cindy H. T. Yeung, Julie Autmizguine, Pooja Dalvi, Audrey Denoncourt, Shinya Ito, Pamela Katz, Mehzabin Rahman, Yves Theoret, Andrea N. Edginton
Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized Therapy
Naïm Bouazza, Saïk Urien, Frantz Foissac, Laure Choupeaux, Gabrielle Lui, Léo Froelicher Bournaud, Steeve Rouillon, Yi Zheng, Emmanuelle Bardin, Nathalie Stremler, Katia Bessaci, Tiphaine Bihouee, Emmanuelle Coirier-Duet, Christophe Marguet, Eric Deneuville, Muriel Laurans, Philippe Reix, Michèle Gerardin, Marie Mittaine, Ralph Epaud, Caroline Thumerelle, Laurence Weiss, Romain Berthaud, Michaela Semeraro, Jean-Marc Treluyer, Sihem Benaboud, Isabelle Sermet-Gaudelus
Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical Care
Marjolein D. van Borselen, Laurens Auke Æmiel Sluijterman, Rick Greupink, Saskia N. de Wildt
A Population Pharmacokinetic Analysis of l-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects
Alina Sadaf, Min Dong, Amanda Pfeiffer, Teresa Latham, Theodosia Kalfa, Alexander A. Vinks, Russell E. Ware, Charles T. Quinn
Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in Neonates
Dua’a Alrahahleh, Yann Thoma, Ruth Van Daele, Thi Nguyen, Stephanie Halena, Melissa Luig, Sophie Stocker, Hannah Yejin Kim, Jan-Willem Alffenaar
Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
Yeamin Huh, Jessica Wojciechowski, Vivek S. Purohit
Comment on: Anti-Coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug–Drug Interactions
Lorenz Van der Linden, Thomas Vanassche, Lucas Van Aelst, Peter Verhamme